XML 19 R27.htm IDEA: XBRL DOCUMENT

Note 8: Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2011

Notes to Condensed Consolidated Financial Statements [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Text Block]

(Dollars in millions)		Balance Sheet Asset Location	September 30, 2011		December 31, 2010

Derivatives designated as hedging instruments:
	Foreign Exchange Contracts	Other assets, current	$	38	$	73
	Foreign Exchange Contracts	Other assets		1		24
				39		97

Derivatives not designated as hedging instruments:
	Foreign Exchange Contracts	Other assets, current		58		31
	Foreign Exchange Contracts	Other assets		4		5
				62		36

Total Asset Derivative Contracts			$	101	$	133

		Balance Sheet Liability Location
Derivatives designated as hedging instruments:
	Foreign Exchange Contracts	Accrued liabilities	$	62	$	16
	Foreign Exchange Contracts	Other long-term liabilities		46		1
				108		17

Derivatives not designated as hedging instruments:
	Foreign Exchange Contracts	Accrued liabilities		74		33
	Foreign Exchange Contracts	Other long-term liabilities		1		3
				75		36

Total Liability Derivative Contracts			$	183	$	53

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Text Block]

	Quarter Ended September 30,				Nine Months Ended September 30,
(Dollars in millions)	2011		2010		2011		2010
(Loss) gain recorded in Accumulated other comprehensive loss	$	(125)	$	63	$	(25)	$	44
Gain reclassified from Accumulated other comprehensive loss into Product sales (effective portion)	$	17	$	35	$	93	$	76

Schedule of Foreign Exchange Contracts Not Designated as Hedges, Gain (Loss) In Statement of Financial Performance [TextBlock]

	Quarter Ended September 30,				Nine Months Ended September 30,
(Dollars in millions)		2011		2010		2011		2010
(Loss) gain recognized in Other income (expense), net	$	(51)	$	107	$	(23)	$	131

Fair Value, Measurement Inputs, Disclosure [Text Block]

(Dollars in millions)	Total Carrying Value at September 30, 2011		Quoted price in active markets (Level 1)		Significant other observable inputs (Level 2)		Unobservable inputs (Level 3)
Available-for-sale securities	$	808	$	808	$	-	$	-
Derivative assets		101		-		101		-
Derivative liabilities		183		-		183		-

(Dollars in millions)	Total Carrying Value at December 31, 2010		Quoted price in active markets (Level 1)		Significant other observable inputs (Level 2)		Unobservable inputs (Level 3)
Available-for-sale securities	$	829	$	829	$	-	$	-
Derivative assets		133		-		133		-
Derivative liabilities		53		-		53		-

Fair Value, by Balance Sheet Grouping [Text Block]

	September 30, 2011				December 31, 2010
(Dollars in millions)	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Long-term receivables	$	276	$	265	$	300	$	276
Customer financing notes receivable		335		326		376		346
Long-term debt (excluding capitalized leases)		(10,079)		(12,045)		(10,117)		(11,500)

- Definition

This element represents the disclosure related to the fair value measurement of assets and liabilities which includes [financial] instruments measured at fair value that are classified in stockholders' equity. Such assets and liabilities may be measured on a recurring or nonrecurring basis. The disclosures which may be required or desired include: (1) for assets and liabilities measured on a recurring basis, disclosure may include: (a) the fair value measurements at the reporting date; (b) the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3); (c) for fair value measurements using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (ii) purchases, sales, issuances, and settlements (net); (iii) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs); (d) the amount of the total gains or losses for the period in subparagraph (c) (i) above included in earnings (or changes in net assets) that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date and a description of where those unrealized gains or losses are reported in the statement of income (or activities); (e) the valuation technique(s) used to measure fair value and a discussion of changes in valuation techniques, if any, during the period and (2) for assets and liabilities that are measured at fair value on a nonrecurring basis (for example, impaired assets) disclosure may include, in addition to (a) above: (a) the reasons for the fair value measurements recorded; (b) the same as (b) above; (c) for fair value measurements using significant unobservable inputs (Level 3), a description of the inputs and the information used to develop the inputs; and (d) the valuation technique(s) used to measure fair value and a discussion of changes, if any, in the valuation technique(s) used to measure similar assets and/or liabilities in prior periods.

+ References+ Details